Annual Shareholders Equity
$186.02 M
+$331.76 M+227.64%
December 31, 2023
Summary
- As of February 7, 2025, NGNE annual stockholders equity is $186.02 million, with the most recent change of +$331.76 million (+227.64%) on December 31, 2023.
- During the last 3 years, NGNE annual shareholders equity has risen by +$277.90 million (+302.48%).
- NGNE annual shareholders equity is now at all-time high.
Performance
NGNE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$137.41 M
-$17.60 M-11.35%
September 30, 2024
Summary
- As of February 7, 2025, NGNE quarterly stockholders equity is $137.41 million, with the most recent change of -$17.60 million (-11.35%) on September 30, 2024.
- Over the past year, NGNE quarterly shareholders equity has increased by +$320.62 million (+175.00%).
- NGNE quarterly shareholders equity is now -26.13% below its all-time high of $186.02 million, reached on December 31, 2023.
Performance
NGNE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NGNE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +227.6% | +175.0% |
| 3 y3 years | +302.5% | - |
| 5 y5 years | +302.5% | - |
NGNE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +227.6% | -26.1% | +175.0% |
| 5 y | 5-year | at high | +227.6% | -26.1% | +175.0% |
| alltime | all time | at high | +227.6% | -26.1% | +175.0% |
Neurogene Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $137.41 M(-11.4%) |
| Jun 2024 | - | $155.01 M(-9.2%) |
| Mar 2024 | - | $170.78 M(-8.2%) |
| Dec 2023 | $186.02 M | $186.02 M(-201.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$183.21 M(+8.4%) |
| Jun 2023 | - | -$169.05 M |
| Dec 2022 | -$145.74 M(+58.6%) | - |
| Dec 2021 | -$91.88 M | - |
FAQ
- What is Neurogene annual stockholders equity?
- What is the all time high annual shareholders equity for Neurogene?
- What is Neurogene annual shareholders equity year-on-year change?
- What is Neurogene quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Neurogene?
- What is Neurogene quarterly shareholders equity year-on-year change?
What is Neurogene annual stockholders equity?
The current annual shareholders equity of NGNE is $186.02 M
What is the all time high annual shareholders equity for Neurogene?
Neurogene all-time high annual stockholders equity is $186.02 M
What is Neurogene annual shareholders equity year-on-year change?
Over the past year, NGNE annual stockholders equity has changed by +$331.76 M (+227.64%)
What is Neurogene quarterly stockholders equity?
The current quarterly shareholders equity of NGNE is $137.41 M
What is the all time high quarterly shareholders equity for Neurogene?
Neurogene all-time high quarterly stockholders equity is $186.02 M
What is Neurogene quarterly shareholders equity year-on-year change?
Over the past year, NGNE quarterly stockholders equity has changed by +$320.62 M (+175.00%)